From: Frailty and hospitalization-associated disability after pneumonia: A prospective cohort study
Outcomes | Number of Outcome Events (%) and OR (95% CI)a | P value | ||||
---|---|---|---|---|---|---|
Total | Robust | Pre-frailty | Mild-to-moderate frailty | Severe frailty | ||
Primary Outcome | ||||||
āDeath or functional decline at 30 daysb | 99 (67.4) | 21 (46.7) | 22 (61.1) | 31 (83.8) | 25 (86.2) | <0.001 |
NA | Reference | 1.46 (0.58-3.69) | 3.95 (1.31-11.89) | 5.34 (1.54-18.49) | 0.014 | |
Secondary patient outcomes | ||||||
āDeath at 30 days | 19 (10.8) | 3 (6.7) | 1 (2.8) | 6 (16.2) | 9 (15.5) | 0.129 |
NA | Reference | 0.38 (0.37-3.84) | 2.36 (0.51-10.94) | 2.27 (0.54-9.62) | 0.281 | |
āFunctional decline at 30 daysb | 84 (63.6) | 18 (42.9) | 21 (60.0) | 25 (80.7) | 20 (83.3) | 0.001 |
NA | Reference | 1.63 (0.63-4.20) | 3.84 (1.24-11.86) | 5.33 (1.50-19.02) | 0.022 | |
Secondary process outcomes | ||||||
āIntensive care unit stay | 38 (21.8) | 4 (8.9) | 8 (22.2) | 9 (24.3) | 17 (30.4) | 0.074 |
NA | Reference | 2.51 (0.67-9.44) | 2.44 (0.64-9.27) | 3.15 (0.92-10.73) | 0.336 | |
āPsychoactive drug usec | 41 (26.5) | 10 (22.2) | 7 (22.6) | 13 (41.9) | 11 (22.9) | 0.189 |
NA | Reference | 0.88 (0.28-2.78) | 1.92 (0.64-5.78) | 0.66 (0.22-1.96) | 0.236 | |
āNasogastric tube feeding | 50 (28.4) | 3 (6.7) | 5 (13.9) | 7 (18.9) | 35 (60.3) | <0.001 |
NA | Reference | 1.97 (0.42-9.22) | 2.50 (0.56-11.22) | 17.08 (4.49-64.99) | <0.001 | |
āProlonged hospitalization (ā„15 days) | 62 (35.6) | 8 (18.2) | 14 (38.9) | 11 (29.7) | 29 (50.9) | 0.006 |
NA | Reference | 2.72 (0.95-7.82) | 1.58 (0.52-4.80) | 3.72 (1.38-9.98) | 0.039 | |
āDischarge to a long-term care institutiond | 39 (27.7) | 2 (4.4) | 7 (20.0) | 14 (41.2) | 16 (59.3) | <0.001 |
NA | Reference | 4.56 (0.83-24.87) | 9.79 (1.88-51.00) | 25.11 (4.70-134.07) | <0.001 |